The U.S. Food and Drug Administration (FDA) said on Friday it has sent letters t...
FILE PHOTO: A Walmart sign is pictured at one of their stores in Mexico City, Mexico March 28, 2019. REUTERS/Edgard Garrido
In the letters, dated April 5, the FDA asked the companies to submit a plan of action within 30 days, describing how they will address and mitigate illegal sales to minors. “We all share the important responsibility of keeping harmful and addictive tobacco products out of the hands of kids. Retailers in particular are on the frontlines of these efforts to reduce the health consequences of tobacco use and nicotine dependence,” the FDA said in the letter.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA threatens to fine Walmart, Kroger and convenience store chains for selling tobacco to minorsThe agency cited high rates of violations in nearly identical letters sent to retailers last week.
Lire la suite »
FDA's stiff warning to health apps highlights opportunity for providersFDA warned mobile health app and devices developers that claim to diagnose traumatic brain injuries, suggesting mHealth market is riddled with flaws.
Lire la suite »
Johnson & Johnson wins U.S. FDA approval for bladder cancer drugJohnson & Johnson's drug Balversa won U.S. approval as the first targeted t...
Lire la suite »
FDA warns companies to stop making ‘unsubstantiated’ claims about CBD curing cancer and Alzheimer’sWarning letters from the FTC and FDA come ahead of a public hearing on the increasingly popular additive.
Lire la suite »
Zogenix stock drops 25% after FDA rejects filingZogenix Inc. shares dropped in the extended session Monday after announcing that the Food and Drug Administration did not accept a marketing application for...
Lire la suite »
Zogenix plummets 30% after FDA refuses to review its seizure treatmentAs part of a preliminary review, FDA determined that the application was not sufficient enough for a substantive review.
Lire la suite »
Analysis | The Health 202: Drug maker accuses FDA of hampering its medication for opioid treatmentThe Health 202: Drug maker accuses FDA of hampering its medication for opioid treatment
Lire la suite »
FDA approves new osteoporosis drugThe US Food and Drug Administration on Tuesday approved the drug Evenity, or romosozumab, to treat osteoporosis in postmenopausal women at high risk of bone fractures.
Lire la suite »
The most common active ingredient in hand sanitizer is still under FDA investigationAfter reviewing the safety and effectiveness of hand sanitizers, the US Food and Drug Administration has ruled that dozens of active ingredients can't be used in the antiseptic rubs, but the agency still wants answers about the most common active ingredient.
Lire la suite »
Five Years After Cancer Warnings, Some Hospitals Still Use Hysterectomy ToolPiedmont Atlanta Hospital lets gynecologists use laparoscopic power morcellators. In the same city, Emory Healthcare stopped using the devices. The contrast underscores a simmering debate.
Lire la suite »